A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors OncoGenex Pharmaceuticals
- 09 Apr 2014 Pharmacokinetic results presented at the 105th Annual Meeting of the American Association for Cancer Research.
- 17 Nov 2008 Actual patient number identified as 821 from ClinicalTrials.gov.
- 17 Nov 2008 Actual trial completion date identified as September 2007 from ClinicalTrials.gov.